NasdaqGS - Nasdaq Real Time Price USD

Akero Therapeutics, Inc. (AKRO)

Compare
54.00
+2.53
+(4.92%)
At close: January 29 at 4:00:01 PM EST
54.20
+0.20
+(0.37%)
After hours: 7:53:21 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
CHENG ANDREW Chief Executive Officer Conversion of Exercise of derivative security Jan 23, 2025 746,062
GANGLOFF SCOTT A. Chief Technology Officer Stock Award(Grant) Dec 16, 2024 24,300
GRAHAM G. WALMSLEY Director Purchase Dec 8, 2023 --
HENDERSON JANE Director Conversion of Exercise of derivative security Jun 16, 2023 0
HEYMAN TOMAS J. Director Conversion of Exercise of derivative security Jun 16, 2023 0
LAMY PATRICK Officer Sale Dec 16, 2024 34,258
ROLPH TIMOTHY PETER Officer Stock Gift Jan 7, 2025 170,237
WHITE WILLIAM RICHARD Chief Financial Officer Stock Award(Grant) Dec 16, 2024 62,635
YALE CATRIONA Officer Conversion of Exercise of derivative security Dec 16, 2024 95,648
YOUNG JONATHAN Chief Operating Officer Conversion of Exercise of derivative security Jan 24, 2025 321,147

Related Tickers